{"id":95732,"date":"2023-11-04T11:44:00","date_gmt":"2023-11-04T10:44:00","guid":{"rendered":"https:\/\/cms.munich-startup.net\/?p=95732"},"modified":"2023-11-03T13:30:28","modified_gmt":"2023-11-03T12:30:28","slug":"epiqmax-acquired-by-moleqlar","status":"publish","type":"post","link":"https:\/\/cms.munich-startup.net\/en\/95732\/epiqmax-acquired-by-moleqlar\/","title":{"rendered":"Epiqmax acquired by Moleqlar"},"content":{"rendered":"
\n

The epigenetics company Epiqmax is now part of the Berlin-based provider of longevity solutions<\/a> Moleqlar. Its product range is designed to combat the signs of aging and improve health indicators at the molecular level.<\/p>\n\n\n\n

Epiqmax was founded in 2018 as a spin-off from LMU and specializes in proteomic analysis and epigenetics. The company offers an epigenetic saliva test that provides deeper insights into how the body functions at the cellular level. In the third quarter of 2023 The biotech startup had to file for bankruptcy<\/a>.<\/p>\n\n\n\n

Maximilian Griessinger<\/strong>, Managing Director of Moleqlar, says:<\/p>\n\n\n\n

"The acquisition of Epiqmax is a strategic move for Moleqlar, and we look forward to welcoming their team of experts and advanced technologies to our company. The integration of Epiqmax's proteomic analysis technologies will significantly expand our analytical and product development capabilities."<\/p><\/blockquote>\n\n\n\n

Moritz V\u00f6lker-Albert<\/strong>, CEO of the newly founded Moleqlar Analytics GmbH (formerly Epiqmax), comments:<\/p>\n\n\n\n

"Epiqmax is excited to become part of the Moleqlar team. Our technical capabilities in proteomic analysis and histone modification quantification will significantly enhance Moleqlar's capabilities and help us leverage epigenetics to sustainably improve people's lives through advanced, personalized healthcare solutions."<\/p><\/blockquote>\n<\/div>","protected":false},"excerpt":{"rendered":"

In the third quarter of this year, the biotech startup Epiqmax filed for insolvency with the local court. Now, the Berlin-based company Moleqlar has acquired the Munich-based epigenetics specialist.<\/p>","protected":false},"author":42,"featured_media":48925,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5633,1],"tags":[371,3625,223],"acf":[],"yoast_head":"\nEpiqmax von Moleqlar \u00fcbernommen - Munich Startup<\/title>\n<meta name=\"description\" content=\"Im dritten Quartal 2023 meldete Epiqmax seine Insolvenz an. Jetzt hat das Berliner Unternehmen Moleqlar den M\u00fcnchner Epigenetik-Spezialisten \u00fcbernommen.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cms.munich-startup.net\/en\/95732\/epiqmax-acquired-by-moleqlar\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Epiqmax von Moleqlar \u00fcbernommen - Munich Startup\" \/>\n<meta property=\"og:description\" content=\"Im dritten Quartal 2023 meldete Epiqmax seine Insolvenz an. Jetzt hat das Berliner Unternehmen Moleqlar den M\u00fcnchner Epigenetik-Spezialisten \u00fcbernommen.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cms.munich-startup.net\/en\/95732\/epiqmax-acquired-by-moleqlar\/\" \/>\n<meta property=\"og:site_name\" content=\"Munich Startup\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/munichstartup\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-04T10:44:00+00:00\" \/>\n<meta name=\"author\" content=\"Saskia Doll\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:site\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Saskia Doll\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cms.munich-startup.net\/95732\/epiqmax-von-moleqlar-uebernommen\/\",\"url\":\"https:\/\/cms.munich-startup.net\/95732\/epiqmax-von-moleqlar-uebernommen\/\",\"name\":\"Epiqmax von Moleqlar \u00fcbernommen - Munich Startup\",\"isPartOf\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cms.munich-startup.net\/95732\/epiqmax-von-moleqlar-uebernommen\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cms.munich-startup.net\/95732\/epiqmax-von-moleqlar-uebernommen\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/05\/Teamfoto_EpiQMAx-e1558967908807.jpg\",\"datePublished\":\"2023-11-04T10:44:00+00:00\",\"author\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/a297bffde6879f56c9ff7b04d9af60b5\"},\"description\":\"Im dritten Quartal 2023 meldete Epiqmax seine Insolvenz an. Jetzt hat das Berliner Unternehmen Moleqlar den M\u00fcnchner Epigenetik-Spezialisten \u00fcbernommen.\",\"breadcrumb\":{\"@id\":\"https:\/\/cms.munich-startup.net\/95732\/epiqmax-von-moleqlar-uebernommen\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cms.munich-startup.net\/95732\/epiqmax-von-moleqlar-uebernommen\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/95732\/epiqmax-von-moleqlar-uebernommen\/#primaryimage\",\"url\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/05\/Teamfoto_EpiQMAx-e1558967908807.jpg\",\"contentUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/05\/Teamfoto_EpiQMAx-e1558967908807.jpg\",\"width\":4383,\"height\":2301,\"caption\":\"Team Epiqmax\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cms.munich-startup.net\/95732\/epiqmax-von-moleqlar-uebernommen\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cms.munich-startup.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Epiqmax von Moleqlar \u00fcbernommen\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cms.munich-startup.net\/#website\",\"url\":\"https:\/\/cms.munich-startup.net\/\",\"name\":\"Munich Startup\",\"description\":\"Das offizielle Startup-Portal f\u00fcr M\u00fcnchen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cms.munich-startup.net\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/a297bffde6879f56c9ff7b04d9af60b5\",\"name\":\"Saskia Doll\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/3cbbe2dd459d277864bc6c7477d0bdf8?s=96&d=blank&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/3cbbe2dd459d277864bc6c7477d0bdf8?s=96&d=blank&r=g\",\"caption\":\"Saskia Doll\"},\"url\":\"https:\/\/cms.munich-startup.net\/en\/author\/doll\/\"}]}<\/script>\n<meta property=\"og:image\" content=\"https:\/\/cms.munich-startup.net\/en\/wp-content\/uploads\/2019\/05\/Teamfoto_EpiQMAx-e1558967908807.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"4383\" \/>\n\t<meta property=\"og:image:height\" content=\"2301\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Epiqmax acquired by Moleqlar - Munich Startup","description":"Epiqmax filed for insolvency in the third quarter of 2023. Now the Berlin-based company Moleqlar has acquired the Munich-based epigenetics specialist.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cms.munich-startup.net\/en\/95732\/epiqmax-acquired-by-moleqlar\/","og_locale":"en_US","og_type":"article","og_title":"Epiqmax von Moleqlar \u00fcbernommen - Munich Startup","og_description":"Im dritten Quartal 2023 meldete Epiqmax seine Insolvenz an. Jetzt hat das Berliner Unternehmen Moleqlar den M\u00fcnchner Epigenetik-Spezialisten \u00fcbernommen.","og_url":"https:\/\/cms.munich-startup.net\/en\/95732\/epiqmax-acquired-by-moleqlar\/","og_site_name":"Munich Startup","article_publisher":"https:\/\/www.facebook.com\/munichstartup\/","article_published_time":"2023-11-04T10:44:00+00:00","author":"Saskia Doll","twitter_card":"summary_large_image","twitter_creator":"@munich_startup","twitter_site":"@munich_startup","twitter_misc":{"Written by":"Saskia Doll","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cms.munich-startup.net\/95732\/epiqmax-von-moleqlar-uebernommen\/","url":"https:\/\/cms.munich-startup.net\/95732\/epiqmax-von-moleqlar-uebernommen\/","name":"Epiqmax acquired by Moleqlar - Munich Startup","isPartOf":{"@id":"https:\/\/cms.munich-startup.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cms.munich-startup.net\/95732\/epiqmax-von-moleqlar-uebernommen\/#primaryimage"},"image":{"@id":"https:\/\/cms.munich-startup.net\/95732\/epiqmax-von-moleqlar-uebernommen\/#primaryimage"},"thumbnailUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/05\/Teamfoto_EpiQMAx-e1558967908807.jpg","datePublished":"2023-11-04T10:44:00+00:00","author":{"@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/a297bffde6879f56c9ff7b04d9af60b5"},"description":"Epiqmax filed for insolvency in the third quarter of 2023. Now the Berlin-based company Moleqlar has acquired the Munich-based epigenetics specialist.","breadcrumb":{"@id":"https:\/\/cms.munich-startup.net\/95732\/epiqmax-von-moleqlar-uebernommen\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cms.munich-startup.net\/95732\/epiqmax-von-moleqlar-uebernommen\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/95732\/epiqmax-von-moleqlar-uebernommen\/#primaryimage","url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/05\/Teamfoto_EpiQMAx-e1558967908807.jpg","contentUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/05\/Teamfoto_EpiQMAx-e1558967908807.jpg","width":4383,"height":2301,"caption":"Team Epiqmax"},{"@type":"BreadcrumbList","@id":"https:\/\/cms.munich-startup.net\/95732\/epiqmax-von-moleqlar-uebernommen\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cms.munich-startup.net\/"},{"@type":"ListItem","position":2,"name":"Epiqmax von Moleqlar \u00fcbernommen"}]},{"@type":"WebSite","@id":"https:\/\/cms.munich-startup.net\/#website","url":"https:\/\/cms.munich-startup.net\/","name":"Munich Startup","description":"The official startup portal for Munich","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cms.munich-startup.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/a297bffde6879f56c9ff7b04d9af60b5","name":"Saskia Doll","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/3cbbe2dd459d277864bc6c7477d0bdf8?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3cbbe2dd459d277864bc6c7477d0bdf8?s=96&d=blank&r=g","caption":"Saskia Doll"},"url":"https:\/\/cms.munich-startup.net\/en\/author\/doll\/"}]},"og_image":[{"width":4383,"height":2301,"url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/05\/Teamfoto_EpiQMAx-e1558967908807.jpg","type":"image\/jpeg"}]},"_showyear":"","_inactive":"","_show_financing":"","_hide_on_map":"","_edit_lock":"1699014631:33","_edit_last":"33","_yoast_wpseo_focuskw":"Epiqmax","_yoast_wpseo_metadesc":"Im dritten Quartal 2023 meldete Epiqmax seine Insolvenz an. Jetzt hat das Berliner Unternehmen Moleqlar den M\u00fcnchner Epigenetik-Spezialisten \u00fcbernommen.","_yoast_wpseo_linkdex":"53","_thumbnail_id":"48925","wbounce_status":"default","_yoast_wpseo_primary_category":"5633","_yoast_wpseo_focuskw_text_input":"","_yoast_wpseo_content_score":"60","ms_image_format":"contentwidth","_ms_image_format":"field_5cb8587572c8b","ms_dachzeile":"","_ms_dachzeile":"field_5cd9b7f365df5","ms_bump_post_date":"","_ms_bump_post_date":"field_5d1341edcf42a","guest_author_name":"","_guest_author_name":"field_5cee78a6016f9","guest_author_image":"","_guest_author_image":"field_5cee7914016fb","guest_author_description":"","_guest_author_description":"field_5cee78dd016fa","ms_post_image_caption":"","_ms_post_image_caption":"field_5f735b0735284","ms_post_image_credit":"","_ms_post_image_credit":"field_5f735b1435285","suppress_startupbox":"0","_suppress_startupbox":"field_60a64b0b6efc6","_yoast_wpseo_estimated-reading-time-minutes":"1","_wp_old_date":"","_yoast_wpseo_title":"","_yoast_wpseo_wordproof_timestamp":"","footnotes":"","easy_language_simplification_original_id":"","easy_language_source_language":"","easy_language_simplification_language":"","easy_language_api":"","easy_language_prevent_automatic_mode":"","_wp_old_slug":"","_wp_trash_meta_status":"","_wp_trash_meta_time":"","easy_language_simplification_state_changed_from":"","easy_language_de_EL_changed":"","ms_competition_deadline":"","_ms_competition_deadline":"","_wpbitly":"","enclosure":"","_yoast_wpseo_meta-robots-noindex":"","_yoast_wpseo_meta-robots-nofollow":"","wbounce_template":"","wbounce_title":"","wbounce_text":"","wbounce_cta":"","wbounce_url":"","wbounce_override":"","_yoast_wpseo_opengraph-title":"","_yoast_wpseo_opengraph-description":"","_oembed_7131efca3705e16bd9da2c41df237660":"","_oembed_time_7131efca3705e16bd9da2c41df237660":"","_pprredirect_type":"","_pprredirect_url":"","_yoast_wpseo_opengraph-image":"","_yoast_wpseo_opengraph-image-id":"","_newsletterglue":"","easy_language_text_language":"","_wp_desired_post_slug":"","_relevanssi_noindex_reason":"","_links":{"self":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/95732"}],"collection":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/users\/42"}],"replies":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/comments?post=95732"}],"version-history":[{"count":2,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/95732\/revisions"}],"predecessor-version":[{"id":95738,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/95732\/revisions\/95738"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media\/48925"}],"wp:attachment":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media?parent=95732"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/categories?post=95732"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/tags?post=95732"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}